Market News & Insights.
A curated feed of headlines from trusted financial sources, refreshed automatically.
Cytokinetics at UBS Global Biopharma Conference 2026: launch gains
ImmunityBio at UBS Global Biopharma Conference 2026: broadening ANKTIVA
IDEAYA at UBS biopharma conference: darovasertib push broadens
Gold Technical Outlook: Is a Rebound Ahead or Another Major Sell-Off?
Idaho Strategic Resources earnings missed by $0.10, revenue fell short of estimates
Gold at a Crossroads: Is the Bull Run Over or Is a Major Crash Looming?
The Crypto Market Has Plummeted to $2.16 Tn, Returning to Its Starting Point
Truist cuts Samsara stock price target to $41 ahead of earnings
Baidu ADR earnings missed by ¥1.38, revenue topped estimates
Analysis-AI selloff has investors scrambling to measure their true exposure
Henry Schein revises non-GAAP reporting, lowers EPS guidance
Kestra study shows 100% shock conversion in wearable defibrillator
Acadia Healthcare Fair Value analysis delivers 65% return in 8 months
GE Power India Q2 FY27 slides: 38% order growth, core services surge
Evercore ISI adds NetApp stock to TAP OP List ahead of earnings
William Blair upgrades Bill.com stock rating on monetization outlook
Cantor Fitzgerald raises CrowdStrike stock price target to $275
Eurozone Industrial Production Recovers
Eurozone industrial production grew for the first time in four months in September, data from Eurostat showed Monday. Industrial output rose 0.2 percent on a monthly basis in September, in contrast to the 0.5 percent decrease seen in August. This was the first increase in four…
ThinkEquity initiates Deep Fission stock coverage with buy rating
US opens probe into more than 1 million Honda vehicles over auto stop-start failures
Analysis-Nike to face doubts about cost-cuts at first investor gathering in years
Papa John’s turns to AI to check pizzas from customers’ photos
Why Nvidia can avoid the fate of most stocks that reached the market-cap apex, according to one strategist
Despite many analysts slashing their forecasts, the median target price for Nvidia remains way above the current share price at $280. Its cash flow and debt profile are the envy of all AI companies and long term, and the stock is attractive, says J.P. Morgan Asset Management.
Toyo Tire cuts full-year guidance on weaker sales
Analysis-Nvidia’s AI financing machine may survive Huang, but with less risk appetite
FTSE 100 Advances 0.4%
U.K. stocks gained modest ground in positive territory on Monday, with investors tracking corporate news and weighing the hawkish comments from Bank of England policymakers, while looking ahead to the crucial inflation data due later in the week.
Coherus Oncology at Jefferies Global Healthcare Conference: tagmokitug takes center stage
Kruk stock falls after Citi downgrades to neutral
Aclaris Therapeutics at Jefferies Global Healthcare Conference: pipeline reset
Headlines and summaries above are provided by their respective publishers via public RSS feeds. Trading & Finance does not claim authorship of this content.